Delivery Order SPE2DB20D1004-SPE2DB23FE7W8
Award Date
10/25/22
Potential Completion Date
10/26/22
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Ramipril 2.5 mg capsules, a cardiovascular medication, to the Defense Logistics Agency (DLA). The contract, valued at $1,894.88, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 30, 2024, with a completion date of January 31, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,727.69, is for the delivery of Ramipril 10 mg capsules. This is a Firm Fixed Price Delivery Order contract with a completion date of July 24, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Ramipril 10 mg capsules. The firm-fixed-price delivery order, valued at $4,289.63, has an ultimate completion date of January 25, 2023. The contract is not designated as a set-aside. Amerisourcebergen is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the Department of...
This federal contract award is for the delivery of Ramipril 2.5 mg capsules to the Defense Logistics Agency (DLA). The $1,131.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 19, 2022. The contract has a completion date of September 20, 2022 and was not set aside for any specific business category. Amerisourcebergen is a major pharmaceutical distributor that holds two significant Indefinite Delivery Contracts (IDCs) with...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,703,727 units of the pharmaceutical product RAMIPRIL 5 MG CAPSULE 100S. The $1,807.84 Firm Fixed Price contract was awarded on May 23, 2024 by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, with an ultimate completion date of May 24, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
This federal contract award, with a ceiling value of $1,604.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,555,086,379 capsules of the pharmaceutical drug Ramipril 2.5 mg. The contract is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...
This federal contract award is for the delivery of 4,564,320 units of Ramipril 10 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $2,389.32, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,915.77 delivery order covers the provision of 4,555,850 units of Ramipril 5 mg capsules to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This $999,999,999 IDC...
This federal contract award, with ID SPE2DB20D1004|SPE2DB22FF1L6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,731.69 delivery order is for the supply of 4556026248 - Ramipril 10 mg capsules, 500s, under a Firm Fixed Price contract. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,616.20 firm fixed-price delivery order covers the supply of RAMIPRIL 10 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of February 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...